Raynaud’s Phenomenon



Raynaud’s Phenomenon


Kyriakos A. Kirou




Raynaud’s phenomenon (RP) is characterized by episodic vasospasm and occlusion of the digital arteries, resulting in a well-demarcated ischemic blanching of the involved digits. This may be followed sequentially by cyanosis and rubor. Tingling may occur during the reactive hyperemia phase (rubor).



  • Exposure to cold or emotional stress is the typical inducer of RP. The duration of an attack may vary from several minutes to hours (usually 10 to 30 minutes). Upper extremities are most frequently involved, but 40% of patients have symptoms in their lower extremities.


  • Primary RP (PRP) is the RP that occurs in otherwise healthy individuals while secondary RP (SRP) is observed in association with other disorders.



    • Proposed criteria for diagnosing PRP include the following:



      • Appearance of symptoms with exposure to cold or emotional upset.


      • Bilateral symmetric involvement of hands.








        Table 17-1 Characteristics of Primary and Secondary RP





































        Primary Secondary
        Women Women (i.e., SSc or SLE) or men (i.e., HAVS and Buerger’s disease)
        Onset often in teens or 20s (<40) Onset in 3rd and 4th decade (i.e., SSc) or even later (i.e., atherosclerosis)
        Familial aggregation Familial and nonfamilial, depending on the cause
        Digital ischemia is episodic (vasospasm in response to cold or emotional stress) Digital ischemia is episodic but can also occur at rest because of structural vascular abnormalities (i.e., SSc and vasculitis)
        Symmetric Symmetric (i.e., SSc) or asymmetric (i.e., atherosclerotic artery occlusion)
        Normal pulse Pulse can be absent or diminished
        No significant tissue ischemic changes Digital pitting, fingertip ulcerations, and gangrene may occur
        Absence of an underlying RP-associated disorder Underlying SSc, MCTD, SLE, vasculitis, etc.
        Serologic tests for ANA and RF are negative and ESR is low Positive ANA (i.e., SLE and SSc) or RF (SS, RA, and MC); high ESR (i.e., vasculitis and multiple myeloma)
        Normal nailfold capillaroscopy Abnormal nailfold capillaries (i.e., SSc, DM, and SLE)
        ANA, antinuclear antibodies; DM, dermatomyositis; ESR, erythrocyte sedimentation rate; HAVS, hand–arm vibration syndrome; MC, mixed cryoglobulinemia; MCTD, mixed connective tissue disease; RA, rheumatoid arthritis; RF, rheumatoid factor; SLE, systemic lupus erythematosus; SS, Sjögren’s syndrome; SSc, systemic sclerosis.



      • Normal pulse.


      • Absence of digital gangrene, or if present, only superficial.


      • Absence of an underlying disorder commonly associated with the symptom complex.


      • Symptoms present for longer than 2 years without the appearance of an underlying cause.


    • In 1992, a stricter definition of PRP was developed that excluded all patients with evidence of digital pitting, ulcerations, or gangrene; abnormal nailfold capillaries; a positive antinuclear antibody (ANA) test; or an abnormal erythrocyte sedimentation rate (ESR) upon presentation.


    • The main characteristics of PRP and SRP are summarized in Table 17-1.


ETIOPATHOGENESIS



  • PRP is caused by vasospasm of the digital arteries and cutaneous arterioles. Its familial predisposition may be due to shared genetic or environmental factors.


  • Vascular tone is determined by the balance of vasoconstrictor and vasodilatory mediators that act on the vascular smooth muscle cells.



    • Vasodilatory neuromediators from sensory (i.e., calcitonin gene-related peptide) and parasympathetic terminals (acetylcholine), as well as vasoconstrictor mediators from sympathetic fibers (i.e., norepinephrine), act on vascular smooth muscle cells to modulate vascular tone.


    • The endothelium plays a central role in mediating the effects of several neurotransmitters (i.e., acetylcholine and neurokinin A), circulating factors (i.e., thrombin and histamine), as well as mechanical shear stress on smooth muscle cells, by producing relaxing (i.e., nitric oxide and prostacyclin or PGI2) or constricting (i.e., endothelin-1) products.



    • Exposure to cold activates vasoconstriction of cutaneous blood vessels by amplifying the effect of norepinephrine on the α2C-adrenoreceptors of the vascular smooth muscle cells.


    • The excessive vasoconstrictive response to cold in RP may be due to increased α2C-adrenoreceptor sensitivity to cold. Other factors likely include a loss of vasodilatory sensory fibers or an overactivity of vasoconstrictive neuromediators. Interestingly, living in cold climates may predispose to PRP.


  • The etiopathogenesis of SRP varies according to the specific associated disorder (Table 17-2).



    • In systemic sclerosis (SSc) or scleroderma, the RP is due to a vasculopathy that mainly affects the cutaneous arterioles/capillaries and the proper digital arteries but often also larger vessels such as the ulnar artery and the superficial palmar arch.



      • Endothelial cell damage or dysfunction is a prominent and early characteristic of this vasculopathy. Reactive oxygen species (ROS) generated during the reperfusion injury from repeated ischemic attacks, as well as antiendothelial antibodies, have been implicated.


      • Histologically, intimal hyperplasia and fibrosis that may be accompanied by thrombosis occur. Adventitial fibrosis and telangiectasias of the vasa vasorum are also common and the former has been implicated in digital ischemia by virtue of external compression.


      • SRP due to mixed connective tissue disease (MCTD) and other scleroderma-overlap syndromes share the same pathogenesis.


    • The SRP associated with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren’s syndrome, and polymyositis is usually benign and vasospastic in nature. However, when caused by vasculitis or thrombosis in the context of the antiphospholipid syndrome, it can lead to tissue damage and gangrene.








      Table 17-2 Causes of Secondary Raynaud’s Phenomenon




      Connective tissue diseases

      • Systemic sclerosis
      • Mixed connective tissue disease
      • Polymyositis and dermatomyositis
      • Systemic lupus erythematosus
      • Sjögren’s syndrome
      • Rheumatoid arthritis

      Systemic vasculitis

      • Polyarteritis nodosa
      • Takayasu’s arteritis
      • Giant cell arteritis
      • Wegener’s granulomatosis
      • Microscopic polyangiitis

      Traumatic vasospastic/occupational

      • Hand–arm vibration syndrome
      • After frostbites

      Occlusive/structural arterial diseases

      • Atherosclerosis
      • Atheroemboli
      • Hypothenar hammer syndrome
      • Thrombangiitis obliterans (Buerger’s disease)

      Nerve compression

      • Thoracic outlet syndrome
      • Carpal tunnel syndrome

      Hematologic disease

      • Cryoglobulinemia
      • Cold agglutinin disease
      • Polycythemia vera
      • Waldenström’s macroglobulinemia

      Drugs and chemicals

      • Ergot alkaloids
      • Methysergide
      • Vinyl chloride
      • Chemotherapy agents (e.g., bleomycin, vinblastine, and cisplatin)
      • β-Blockers
      • Sympathomimetics
      • Anticholinergics
      • Cyclosporine A
      • Interferon-α

      Other disorders

      • Hypothyroidism
      • Complex regional pain syndrome type 1
      • Paraneoplastic



    • In systemic vasculitis, the inflammatory occlusion of vessels usually leads to severe digital ischemia and gangrene.


    • The hand–arm vibration syndrome (HAVS) or vibration-induced white finger (VWF) occurs in workers who use vibratory tools such as pneumatic hammers and chain saws.

      Only gold members can continue reading. Log In or Register to continue

      Stay updated, free articles. Join our Telegram channel

Jul 29, 2016 | Posted by in RHEUMATOLOGY | Comments Off on Raynaud’s Phenomenon

Full access? Get Clinical Tree

Get Clinical Tree app for offline access